Phase I pharmacokinetic study of 2-methoxyestradiol (2ME2) in healthy volunteers

Trial Profile

Phase I pharmacokinetic study of 2-methoxyestradiol (2ME2) in healthy volunteers

Planning
Phase of Trial: Phase I

Latest Information Update: 31 Mar 2015

At a glance

  • Drugs 2-methoxyestradiol (Primary)
  • Indications Rheumatoid arthritis
  • Focus Pharmacokinetics
  • Sponsors CASI Pharmaceuticals
  • Most Recent Events

    • 31 Mar 2015 New trial record
    • 27 Mar 2015 This trial is expected to be initiated in 2015, according to a CASI Pharmaceuticals media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top